$CL
COLGATE PALMOLIVE CO Stock $cl

$cl Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000002166522000003 Filed on February 17, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$4.403B	$17.42B	$4.324B
YoY Change	1.83%	5.77%	7.7%
Cost Of Revenue	$1.844B	$7.046B	$1.681B
YoY Change	9.7%	9.17%	4.93%
Gross Profit	$2.559B	$10.38B	$2.643B
YoY Change	-3.18%	3.57%	9.49%
Gross Profit Margin	58.12%	59.55%	61.12%
Selling, General & Admin	$1.598B	$6.407B	$1.633B
YoY Change	-2.14%	6.45%	17.14%
% of Gross Profit	62.45%	61.75%	61.79%
Research & Development		$307.0M
YoY Change		5.86%
% of Gross Profit		2.96%
Depreciation & Amortization	$142.0M	$556.0M	$139.0M
YoY Change	2.16%	3.15%	4.51%
% of Gross Profit	5.55%	5.36%	5.26%
Operating Expenses	$1.623B	$6.714B	$1.674B
YoY Change	-3.05%	6.42%	15.37%
Operating Profit	$936.0M	$3.332B	$969.0M
YoY Change	-3.41%	-14.23%	0.62%
Interest Expense	-$23.00M	-$163.0M	-$57.00M
YoY Change	-59.65%	7.24%	78.13%
% of Operating Profit	-2.46%	-4.89%	-5.88%
Other Income/Expense, Net	-$18.00M	-$70.00M	-$18.00M
YoY Change	0.0%	-5.41%	-30.77%
Pretax Income	$324.0M	$3.087B	$894.0M
YoY Change	-63.76%	-15.36%	2.76%
Income Tax	$136.0M	$749.0M	$202.0M
% Of Pretax Income	41.98%	24.26%	22.6%
Net Earnings	$148.0M	$2.166B	$647.0M
YoY Change	-77.13%	-19.63%	0.62%
Net Earnings / Revenue	3.36%	12.43%	14.96%
Basic Earnings Per Share		$2.56	$0.76
Diluted Earnings Per Share	$174.9K	$2.55	$0.75
COMMON SHARES
Basic Shares Outstanding		845.0M shares
Diluted Shares Outstanding		848.3M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$866.0M	$866.0M	$925.0M
YoY Change	-6.38%	-6.38%	2.1%
Cash & Equivalents	$832.0M	$832.0M	$888.0M
Short-Term Investments	$34.00M	$34.00M	$37.00M
Other Short-Term Assets	$576.0M	$542.0M	$513.0M
YoY Change	12.28%	13.87%	12.5%
Inventory	$1.692B	$1.692B	$1.673B
Prepaid Expenses
Receivables	$1.297B	$1.297B	$1.264B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.397B	$4.397B	$4.338B
YoY Change	1.36%	1.36%	3.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.730B	$4.257B	$3.716B
YoY Change	0.38%	0.47%	-0.91%
Goodwill	$3.284B		$3.824B
YoY Change	-14.12%		9.01%
Intangibles	$2.462B		$2.894B
YoY Change	-14.93%		8.51%
Long-Term Investments	$64.00M	$64.00M	$56.00M
YoY Change	14.29%	14.29%	12.0%
Other Assets	$974.0M	$576.0M	$857.0M
YoY Change	13.65%	0.88%	13.81%
Total Long-Term Assets	$10.64B	$10.64B	$11.58B
YoY Change	-8.11%	-8.11%	6.7%
TOTAL ASSETS
Total Short-Term Assets	$4.397B	$4.397B	$4.338B
Total Long-Term Assets	$10.64B	$10.64B	$11.58B
Total Assets	$15.04B	$15.04B	$15.92B
YoY Change	-5.53%	-5.53%	5.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.479B	$1.479B	$1.393B
YoY Change	6.17%	6.17%	12.61%
Accrued Expenses	$2.085B	$2.079B	$2.248B
YoY Change	-7.25%	-7.52%	19.19%
Deferred Revenue
YoY Change
Short-Term Debt	$39.00M	$39.00M	$258.0M
YoY Change	-84.88%	-84.88%	-0.77%
Long-Term Debt Due	$12.00M	$12.00M	$9.000M
YoY Change	33.33%	33.33%	-96.46%
Total Short-Term Liabilities	$4.051B	$4.051B	$4.404B
YoY Change	-8.02%	-8.02%	9.06%
LONG-TERM LIABILITIES
Long-Term Debt	$7.194B	$7.194B	$7.334B
YoY Change	-1.91%	-1.91%	0.01%
Other Long-Term Liabilities	$2.429B	$2.429B	$2.655B
YoY Change	-8.51%	-8.51%	2.19%
Total Long-Term Liabilities	$9.623B	$9.623B	$9.989B
YoY Change	-3.66%	-3.66%	0.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.051B	$4.051B	$4.404B
Total Long-Term Liabilities	$9.623B	$9.623B	$9.989B
Total Liabilities	$14.07B	$14.43B	$14.82B
YoY Change	-5.06%	-4.92%	2.37%
SHAREHOLDERS EQUITY
Retained Earnings	$24.35B		$23.70B
YoY Change	2.75%		5.32%
Common Stock	$1.466B		$1.466B
YoY Change	0.0%		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$24.09B		$23.05B
YoY Change	4.53%		4.45%
Treasury Stock Shares	625.2M shares		615.8M shares
Shareholders Equity	$609.0M	$609.0M	$743.0M
YoY Change
Total Liabilities & Shareholders Equity	$15.04B	$15.04B	$15.92B
YoY Change	-5.53%	-5.53%	5.89%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$148.0M	$2.166B	$647.0M
YoY Change	-77.13%	-19.63%	0.62%
Depreciation, Depletion And Amortization	$142.0M	$556.0M	$139.0M
YoY Change	2.16%	3.15%	4.51%
Cash From Operating Activities	$1.106B	$3.325B	$963.0M
YoY Change	14.85%	-10.59%	-0.72%
INVESTING ACTIVITIES
Capital Expenditures	-$193.0M	$567.0M	-$161.0M
YoY Change	19.88%	38.63%	47.71%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	$63.00M	$25.00M	$50.00M
YoY Change	26.0%	-933.33%	-41.18%
Cash From Investing Activities	-$130.0M	-$592.0M	-$111.0M
YoY Change	17.12%	-24.01%	362.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$1.320B
YoY Change		-10.57%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.106B	-$2.774B	-951.0M
YoY Change	16.3%	-4.97%	-6.76%
NET CHANGE
Cash From Operating Activities	1.106B	$3.325B	963.0M
Cash From Investing Activities	-130.0M	-$592.0M	-111.0M
Cash From Financing Activities	-1.106B	-$2.774B	-951.0M
Net Change In Cash	-130.0M	-$56.00M	-99.00M
YoY Change	31.31%	-1220.0%	33.78%
FREE CASH FLOW
Cash From Operating Activities	$1.106B	$3.325B	$963.0M
Capital Expenditures	-$193.0M	$567.0M	-$161.0M
Free Cash Flow	$1.299B	$2.758B	$1.124B
YoY Change	15.57%	-16.68%	4.17%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0000021665
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAccruedLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAccruedLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	1-644
CY2021	dei	Entity Registrant Name EntityRegistrantName	COLGATE-PALMOLIVE COMPANY
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-1815595
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	300 Park Avenue
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	New York,
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
CY2021	dei	City Area Code CityAreaCode	212
CY2021	dei	Local Phone Number LocalPhoneNumber	310-2000
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	68600000000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	840487222	shares
CY2021	dei	Auditor Firm AuditorFirmId	238
CY2021	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2021	dei	Auditor Location AuditorLocation	New York, New York
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17421000000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16471000000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15693000000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	7046000000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	6454000000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	6368000000	USD
CY2021	us-gaap	Gross Profit GrossProfit	10375000000	USD
CY2020	us-gaap	Gross Profit GrossProfit	10017000000	USD
CY2019	us-gaap	Gross Profit GrossProfit	9325000000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6407000000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6019000000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5575000000	USD
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-65000000	USD
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-113000000	USD
CY2019	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-196000000	USD
CY2021	cl	Goodwill And Indefinite Lived Intangibles Impairment Charges GoodwillAndIndefiniteLivedIntangiblesImpairmentCharges	571000000	USD
CY2020	cl	Goodwill And Indefinite Lived Intangibles Impairment Charges GoodwillAndIndefiniteLivedIntangiblesImpairmentCharges	0	USD
CY2019	cl	Goodwill And Indefinite Lived Intangibles Impairment Charges GoodwillAndIndefiniteLivedIntangiblesImpairmentCharges	0	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	3332000000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	3885000000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	3554000000	USD
CY2021	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	70000000	USD
CY2020	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	74000000	USD
CY2019	us-gaap	Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent	108000000	USD
CY2021	cl	Interest Expense Net InterestExpenseNet	175000000	USD
CY2020	cl	Interest Expense Net InterestExpenseNet	164000000	USD
CY2019	cl	Interest Expense Net InterestExpenseNet	145000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3087000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3647000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3301000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	749000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	787000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	774000000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	2338000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	2860000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	2527000000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	172000000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	165000000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	160000000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	2166000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	2695000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	2367000000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.56
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.15
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.76
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.55
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.14
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.75
CY2021	us-gaap	Profit Loss ProfitLoss	2338000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	2860000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	2527000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-193000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-24000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	25000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-134000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	40000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	100000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	16000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-2000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-12000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-43000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-66000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-87000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2295000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2794000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2440000000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	172000000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	165000000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	160000000	USD
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-2000000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	6000000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-2000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	170000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	171000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	158000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2125000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2623000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2282000000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	832000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	888000000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	78000000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	89000000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1297000000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1264000000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	1692000000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1673000000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	576000000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	513000000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	4397000000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	4338000000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3730000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3716000000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	3284000000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	3824000000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2462000000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2894000000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	193000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	291000000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	974000000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	857000000	USD
CY2021Q4	us-gaap	Assets Assets	15040000000	USD
CY2020Q4	us-gaap	Assets Assets	15920000000	USD
CY2021Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	39000000	USD
CY2020Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	258000000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	12000000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	9000000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1479000000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1393000000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	436000000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	403000000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2085000000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2341000000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4051000000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4404000000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7194000000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7334000000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	395000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	426000000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2429000000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2655000000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	14069000000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	14819000000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1465706360	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1465706360	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1466000000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1466000000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3269000000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2969000000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	24350000000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	23699000000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4386000000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4345000000	USD
CY2021Q4	cl	Unearned Compensation UnearnedCompensation	1000000	USD
CY2020Q4	cl	Unearned Compensation UnearnedCompensation	1000000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	24089000000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	23045000000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	609000000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	743000000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	362000000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	358000000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	971000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1101000000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15040000000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15920000000	USD
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.71
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.75
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.79
CY2020Q1	cl	Number Of Dividends Declared Per Quarter NumberOfDividendsDeclaredPerQuarter	2	Dividend
CY2021Q1	cl	Number Of Dividends Declared Per Quarter NumberOfDividendsDeclaredPerQuarter	2	Dividend
CY2019Q1	cl	Number Of Dividends Declared Per Quarter NumberOfDividendsDeclaredPerQuarter	2	Dividend
CY2021	us-gaap	Profit Loss ProfitLoss	2338000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	2860000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	2527000000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	556000000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	539000000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	519000000	USD
CY2021	cl	Restructuring Net Of Cash RestructuringNetOfCash	-21000000	USD
CY2020	cl	Restructuring Net Of Cash RestructuringNetOfCash	-71000000	USD
CY2019	cl	Restructuring Net Of Cash RestructuringNetOfCash	18000000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	135000000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	107000000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	100000000	USD
CY2021	cl	Goodwill And Indefinite Lived Intangibles Impairment Charges GoodwillAndIndefiniteLivedIntangiblesImpairmentCharges	571000000	USD
CY2020	cl	Goodwill And Indefinite Lived Intangibles Impairment Charges GoodwillAndIndefiniteLivedIntangiblesImpairmentCharges	0	USD
CY2019	cl	Goodwill And Indefinite Lived Intangibles Impairment Charges GoodwillAndIndefiniteLivedIntangiblesImpairmentCharges	0	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-75000000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-23000000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-132000000	USD
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-120000000	USD
CY2019	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	17000000	USD
CY2021	us-gaap	Pension And Other Postretirement Benefit Contributions PensionAndOtherPostretirementBenefitContributions	0	USD
CY2020	us-gaap	Pension And Other Postretirement Benefit Contributions PensionAndOtherPostretirementBenefitContributions	0	USD
CY2019	us-gaap	Pension And Other Postretirement Benefit Contributions PensionAndOtherPostretirementBenefitContributions	113000000	USD
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	84000000	USD
CY2020	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-138000000	USD
CY2019	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-19000000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	72000000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	251000000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	77000000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	14000000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	520000000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	36000000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	55000000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	26000000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-87000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3325000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3719000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3133000000	USD
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	567000000	USD
CY2020	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	410000000	USD
CY2019	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	335000000	USD
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	141000000	USD
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	143000000	USD
CY2019	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	184000000	USD
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	141000000	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	124000000	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	131000000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	353000000	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1711000000	USD
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	25000000	USD
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-3000000	USD
CY2019	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-592000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-779000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2099000000	USD
CY2021	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	-171000000	USD
CY2020	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	488000000	USD
CY2019	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	296000000	USD
CY2021	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	703000000	USD
CY2020	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	1085000000	USD
CY2019	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	1441000000	USD
CY2021	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	699000000	USD
CY2020	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	0	USD
CY2019	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	2578000000	USD
CY2021	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	1679000000	USD
CY2020	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	1654000000	USD
CY2019	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	1614000000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1320000000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1476000000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1202000000	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	424000000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	874000000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	498000000	USD
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	99000000	USD
CY2019	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-24000000	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	33000000	USD
CY2019	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	15000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2774000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2919000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-870000000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-15000000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-16000000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-7000000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-56000000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5000000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	157000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	888000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	883000000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	726000000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	832000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	888000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	883000000	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	890000000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	845000000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	803000000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	194000000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	188000000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	185000000	USD
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	75000000	USD
CY2020	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	20000000	USD
CY2021	us-gaap	Nature Of Operations NatureOfOperations	Nature of Operations <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manufactures and markets a wide variety of products in the U.S. and around the world in two product segments: Oral, Personal and Home Care; and Pet Nutrition. Oral, Personal and Home Care products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners and other similar items. These products are sold primarily to a variety of traditional and eCommerce retailers, wholesalers and distributors worldwide. Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The principal customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and eCommerce retailers. Some of our products are also sold direct-to-consumer. Principal global and regional trademarks include Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.060%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.060%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.063%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home Care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pet Nutrition</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>
CY2021	cl	Number Of Product Segments NumberOfProductSegments	2	business_segment
CY2021Q4	cl	Equity Method Investment Ownership Percentage Minimum EquityMethodInvestmentOwnershipPercentageMinimum	0.20
CY2021Q4	cl	Equity Method Investment Ownership Percentage Maximum EquityMethodInvestmentOwnershipPercentageMaximum	0.50
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	64000000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	56000000	USD
CY2021Q4	cl	Cost Method Investment Ownership Percentage Maximum CostMethodInvestmentOwnershipPercentageMaximum	0.20
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairments, uncertain tax positions, tax valuation allowances and legal and other contingency reserves. Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates.</span></div>
CY2021Q4	us-gaap	Percentage Of Fifo Inventory PercentageOfFIFOInventory	0.75
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	ReclassificationsCertain prior year amounts have been reclassified to conform to the current year presentation.
CY2021Q4	us-gaap	Goodwill Goodwill	3284000000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	3824000000	USD
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3196000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	734000000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2462000000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3553000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	659000000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2894000000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	89000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	77000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	77000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	77000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	77000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	77000000	USD
CY2021Q4	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	204000000	USD
CY2021Q4	cl	Reporting Unit Impairment Analysis Projected Reduction Of Carrying Amount ReportingUnitImpairmentAnalysisProjectedReductionOfCarryingAmount	588000000	USD
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	7206000000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	7343000000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	12000000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	9000000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7194000000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7334000000	USD
CY2021Q4	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.007
CY2020Q4	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.048
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	456000000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	908000000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	506000000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	135000000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	566000000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	3431000000	USD
CY2021	us-gaap	Debt Instrument Term DebtInstrumentTerm	P364D
CY2021	cl	Minimum Number Of Countries And Territories Serving Consumers MinimumNumberOfCountriesAndTerritoriesServingConsumers	200	country_and_territory
CY2021Q4	us-gaap	Derivative Assets DerivativeAssets	49000000	USD
CY2020Q4	us-gaap	Derivative Assets DerivativeAssets	29000000	USD
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	27000000	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	93000000	USD
CY2021Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	34000000	USD
CY2020Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	37000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	13000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	-3000000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50262150	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	862912792	shares
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	602793568	shares
CY2019	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	17219642	shares
CY2019	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	17219642	shares
CY2019	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	8145777	shares
CY2019	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	8145777	shares
CY2019	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	862852	shares
CY2019	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	862852	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	854701779	shares
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	611004581	shares
CY2020	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	18701843	shares
CY2020	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	18701843	shares
CY2020	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	13018354	shares
CY2020	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	13018354	shares
CY2020	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	875311	shares
CY2020	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	875311	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	849893601	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	615812759	shares
CY2021	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	16518163	shares
CY2021	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	16518163	shares
CY2021	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	6357793	shares
CY2021	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	6357793	shares
CY2021	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	747053	shares
CY2021	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	747053	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	840480284	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	625226076	shares
CY2021Q4	cl	Numberof Stockholder Approved Plans Current NumberofStockholderApprovedPlansCurrent	1	plan
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	135000000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	107000000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	100000000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	25000000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	20000000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	20000000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.11
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.26
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.48
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.203
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.218
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.192
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.010
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.005
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.015
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.023
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.023
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.023
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	27530000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	71
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	5120000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	77
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	6358000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	68
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	173000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	75
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	24000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	73
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	26095000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	72
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q4	us-gaap	Employee Stock Ownership Plan Esop Number Of Allocated Shares EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares	9559255	shares
CY2021	cl	Expected Benefit Payments From Company Assets ExpectedBenefitPaymentsFromCompanyAssets	89000000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	309000000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	16725000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	72
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	223000000	USD
CY2021	cl	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options And Vesting Of Restricted Stock Unit Awards EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptionsAndVestingOfRestrictedStockUnitAwards	9000000	USD
CY2020	cl	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options And Vesting Of Restricted Stock Unit Awards EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptionsAndVestingOfRestrictedStockUnitAwards	8000000	USD
CY2019	cl	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options And Vesting Of Restricted Stock Unit Awards EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptionsAndVestingOfRestrictedStockUnitAwards	6000000	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	424000000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	874000000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	498000000	USD
CY2021Q4	us-gaap	Employee Stock Ownership Plan Esop Shares In Esop EmployeeStockOwnershipPlanESOPSharesInESOP	10290667	shares
CY2020Q4	us-gaap	Employee Stock Ownership Plan Esop Shares In Esop EmployeeStockOwnershipPlanESOPSharesInESOP	11545950	shares
CY2021Q4	cl	Employee Stock Ownership Plan Esop Debt Structure Employer Loan Amount EmployeeStockOwnershipPlanESOPDebtStructureEmployerLoanAmount	1000000	USD
CY2021Q4	us-gaap	Employee Stock Ownership Plan Esop Number Of Suspense Shares EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares	731412	shares
CY2021	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	0	USD
CY2020	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	0	USD
CY2019	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	0	USD
CY2021	us-gaap	Employee Stock Ownership Plan Esop Dividends Paid To Esop EmployeeStockOwnershipPlanESOPDividendsPaidToESOP	20000000	USD
CY2020	us-gaap	Employee Stock Ownership Plan Esop Dividends Paid To Esop EmployeeStockOwnershipPlanESOPDividendsPaidToESOP	23000000	USD
CY2019	us-gaap	Employee Stock Ownership Plan Esop Dividends Paid To Esop EmployeeStockOwnershipPlanESOPDividendsPaidToESOP	25000000	USD
CY2021	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	0	USD
CY2019	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	0	USD
CY2020	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	0	USD
CY2021Q4	cl	Percentage Of Fixed Income Portfolio Invested In Us Treasury Or Agency Securities PercentageOfFixedIncomePortfolioInvestedInUsTreasuryOrAgencySecurities	0.40
CY2020Q4	cl	Percentage Of Fixed Income Portfolio Invested In Us Treasury Or Agency Securities PercentageOfFixedIncomePortfolioInvestedInUsTreasuryOrAgencySecurities	0.50
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	237000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	234000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	241000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	238000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	244000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	1205000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1256000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1317000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1050000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1831000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2330000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2251000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3087000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3647000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3301000000	USD
CY2021	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	228000000	USD
CY2020	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	259000000	USD
CY2019	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	180000000	USD
CY2021	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	521000000	USD
CY2020	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	528000000	USD
CY2019	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	594000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	749000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	787000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	774000000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	-50000000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	-1000000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	-34000000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Depreciation IncomeTaxReconciliationNondeductibleExpenseDepreciation	19000000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Depreciation IncomeTaxReconciliationNondeductibleExpenseDepreciation	-12000000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Depreciation IncomeTaxReconciliationNondeductibleExpenseDepreciation	-12000000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	4000000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-10000000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	13000000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-11000000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	7000000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1000000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Leases IncomeTaxReconciliationNondeductibleExpenseLeases	2000000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Leases IncomeTaxReconciliationNondeductibleExpenseLeases	1000000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Leases IncomeTaxReconciliationNondeductibleExpenseLeases	0	USD
CY2021	cl	Effective Income Tax Reconciliation Tax Loss And Tax Credit Carryforwards EffectiveIncomeTaxReconciliationTaxLossAndTaxCreditCarryforwards	-2000000	USD
CY2020	cl	Effective Income Tax Reconciliation Tax Loss And Tax Credit Carryforwards EffectiveIncomeTaxReconciliationTaxLossAndTaxCreditCarryforwards	-1000000	USD
CY2019	cl	Effective Income Tax Reconciliation Tax Loss And Tax Credit Carryforwards EffectiveIncomeTaxReconciliationTaxLossAndTaxCreditCarryforwards	3000000	USD
CY2021	cl	Effective Income Tax Rate Reconciliation Deferred Withholding Tax Amount EffectiveIncomeTaxRateReconciliationDeferredWithholdingTaxAmount	16000000	USD
CY2020	cl	Effective Income Tax Rate Reconciliation Deferred Withholding Tax Amount EffectiveIncomeTaxRateReconciliationDeferredWithholdingTaxAmount	-111000000	USD
CY2019	cl	Effective Income Tax Rate Reconciliation Deferred Withholding Tax Amount EffectiveIncomeTaxRateReconciliationDeferredWithholdingTaxAmount	21000000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-19000000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-18000000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	33000000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-37000000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-143000000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	19000000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.011
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.010
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.006
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.027
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.033
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.046
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Foreign EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Foreign EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign	-0.020
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Foreign EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign	-0.009
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.022
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0
CY2021	cl	Effective Income Tax Rate Reconciliation Foreign Derived Intangible Income Benefit Percent EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeBenefitPercent	-0.022
CY2020	cl	Effective Income Tax Rate Reconciliation Foreign Derived Intangible Income Benefit Percent EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeBenefitPercent	-0.016
CY2019	cl	Effective Income Tax Rate Reconciliation Foreign Derived Intangible Income Benefit Percent EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeBenefitPercent	-0.013
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.005
CY2020Q4	cl	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Lease Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiabilities	144000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	234000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	250000000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.006
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.243
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.216
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.234
CY2020	cl	Discrete Income Tax Provision Benefit DiscreteIncomeTaxProvisionBenefit	-71000000	USD
CY2020	cl	Foreign Withholding Income Tax ForeignWithholdingIncomeTax	-45000000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-26000000	USD
CY2021Q4	cl	Withholding Tax Due WithholdingTaxDue	0	USD
CY2021	cl	Foreign Withholding Income Tax ForeignWithholdingIncomeTax	-45000000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-26000000	USD
CY2019	cl	Income Tax Benefit Related To Changes In Swiss Preferential Tax Regime And Increase To Cantonal Tax Rate IncomeTaxBenefitRelatedToChangesInSwissPreferentialTaxRegimeAndIncreaseToCantonalTaxRate	29000000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	523000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	603000000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	301000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	281000000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	125000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	131000000	USD
CY2021Q4	cl	Deferred Tax Liabilities Deferred Withholding Tax DeferredTaxLiabilitiesDeferredWithholdingTax	111000000	USD
CY2020Q4	cl	Deferred Tax Liabilities Deferred Withholding Tax DeferredTaxLiabilitiesDeferredWithholdingTax	95000000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	35000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	52000000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1095000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1162000000	USD
CY2021Q4	cl	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions And Other Retiree Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensionsAndOtherRetireeBenefits	344000000	USD
CY2020Q4	cl	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions And Other Retiree Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensionsAndOtherRetireeBenefits	404000000	USD
CY2021Q4	cl	Deferred Tax Assets Tax Loss And Tax Credit Carryforwards DeferredTaxAssetsTaxLossAndTaxCreditCarryforwards	152000000	USD
CY2020Q4	cl	Deferred Tax Assets Tax Loss And Tax Credit Carryforwards DeferredTaxAssetsTaxLossAndTaxCreditCarryforwards	127000000	USD
CY2021Q4	cl	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Lease Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiabilities	138000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	76000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	73000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	69000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	125000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1013000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1123000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	120000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	96000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	893000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1027000000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	202000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	135000000	USD
CY2021	us-gaap	Income Tax Effects Allocated Directly To Equity IncomeTaxEffectsAllocatedDirectlyToEquity	146000000	USD
CY2020	us-gaap	Income Tax Effects Allocated Directly To Equity IncomeTaxEffectsAllocatedDirectlyToEquity	-101000000	USD
CY2019	us-gaap	Income Tax Effects Allocated Directly To Equity IncomeTaxEffectsAllocatedDirectlyToEquity	-13000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	227000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	173000000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	190000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	26000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	18000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	14000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	20000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	5000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	21000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	40000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	57000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	20000000	USD
CY2021	cl	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities And Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthoritiesAndLapseOfApplicableStatuteOfLimitations	23000000	USD
CY2020	cl	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities And Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthoritiesAndLapseOfApplicableStatuteOfLimitations	19000000	USD
CY2019	cl	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities And Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthoritiesAndLapseOfApplicableStatuteOfLimitations	30000000	USD
CY2021	cl	Unrecognized Tax Benefits Effect Of Foreign Currency Rate Movements UnrecognizedTaxBenefitsEffectOfForeignCurrencyRateMovements	5000000	USD
CY2020	cl	Unrecognized Tax Benefits Effect Of Foreign Currency Rate Movements UnrecognizedTaxBenefitsEffectOfForeignCurrencyRateMovements	-3000000	USD
CY2019	cl	Unrecognized Tax Benefits Effect Of Foreign Currency Rate Movements UnrecognizedTaxBenefitsEffectOfForeignCurrencyRateMovements	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	245000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	227000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	173000000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	235000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	10000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	9000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	35000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	24000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	23000000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2166000000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	845000000.0	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.56
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2695000000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	856800000	shares
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.15
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2367000000	USD
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	859100000	shares
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.76
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3300000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2500000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2000000.0	shares
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2166000000	USD
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	848300000	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.55
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2695000000	USD
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	859300000	shares
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.14
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2367000000	USD
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	861100000	shares
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.75
CY2021	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	724000000	USD
CY2021Q4	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	200	country_and_territory
CY2021Q4	cl	Tax Assessments With Interest TaxAssessmentsWithInterest	106000000	USD
CY2021	cl	Loss Contingency Number Of Cases On Appeal LossContingencyNumberOfCasesOnAppeal	5	case
CY2005Q4	cl	Tax Assessments With Interest And Penalties TaxAssessmentsWithInterestAndPenalties	47000000	USD
CY2017Q3	cl	Fine Imposed By Greek Competition Authority FineImposedByGreekCompetitionAuthority	11000000	USD
CY2019Q2	cl	Increase Decrease In Fine Imposed By Greek Competition Authority IncreaseDecreaseInFineImposedByGreekCompetitionAuthority	-10500000	USD
CY2021Q4	us-gaap	Loss Contingency Pending Claims Number LossContingencyPendingClaimsNumber	171	case
CY2020Q4	us-gaap	Loss Contingency Pending Claims Number LossContingencyPendingClaimsNumber	136	case
CY2021	us-gaap	Loss Contingency New Claims Filed Number LossContingencyNewClaimsFiledNumber	74	case
CY2021	us-gaap	Loss Contingency Claims Settled And Dismissed Number LossContingencyClaimsSettledAndDismissedNumber	39	case
CY2021	cl	Number Of Product Segments NumberOfProductSegments	2	business_segment
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	5	business_segment
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	5	business_segment
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17421000000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16471000000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15693000000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	3332000000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	3885000000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	3554000000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	567000000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	409000000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	335000000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	556000000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	539000000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	519000000	USD
CY2021Q4	us-gaap	Assets Assets	15040000000	USD
CY2020Q4	us-gaap	Assets Assets	15920000000	USD
CY2019Q4	us-gaap	Assets Assets	15034000000	USD
CY2021Q4	cl	Percentage Of Corporate Identifiable Assets Consisting Of Investments In Equity Securities PercentageOfCorporateIdentifiableAssetsConsistingOfInvestmentsInEquitySecurities	0.87
CY2021Q4	cl	Percentage Of Corporate Identifiable Assets Consisting Of Derivative Instruments PercentageOfCorporateIdentifiableAssetsConsistingOfDerivativeInstruments	0.10
CY2020Q4	cl	Percentage Of Corporate Identifiable Assets Consisting Of Investments In Equity Securities PercentageOfCorporateIdentifiableAssetsConsistingOfInvestmentsInEquitySecurities	0.95
CY2019Q4	cl	Percentage Of Corporate Identifiable Assets Consisting Of Investments In Equity Securities PercentageOfCorporateIdentifiableAssetsConsistingOfInvestmentsInEquitySecurities	0.92
CY2019Q4	cl	Percentage Of Corporate Identifiable Assets Consisting Of Derivative Instruments PercentageOfCorporateIdentifiableAssetsConsistingOfDerivativeInstruments	0.02
CY2021Q4	cl	Total Long Lived Assets TotalLongLivedAssets	4256000000	USD
CY2020Q4	cl	Total Long Lived Assets TotalLongLivedAssets	4237000000	USD
CY2019Q4	cl	Total Long Lived Assets TotalLongLivedAssets	4254000000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	527000000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	521000000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	137000000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	137000000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	451000000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	476000000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	588000000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	613000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	156000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	109000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	76000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	61000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	48000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	235000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	685000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	97000000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	588000000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	142000000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	155000000	USD
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	7000000	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3000000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	20000000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	20000000	USD
CY2021	us-gaap	Sublease Income SubleaseIncome	1000000	USD
CY2019	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	57000000	USD
CY2020	us-gaap	Sublease Income SubleaseIncome	0	USD
CY2021	us-gaap	Lease Cost LeaseCost	168000000	USD
CY2020	us-gaap	Lease Cost LeaseCost	178000000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	173000000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	193000000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	197000000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	163000000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042
CY2021	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	0	USD
CY2020	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	-13000000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	89000000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	88000000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62000000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	12000000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	12000000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	9000000	USD
CY2021	cl	Benefit From Foreign Tax Matter Brazil BenefitFromForeignTaxMatterBrazil	26000000	USD
CY2020	cl	Benefit From Foreign Tax Matter Brazil BenefitFromForeignTaxMatterBrazil	0	USD
CY2019	cl	Benefit From Foreign Tax Matter Brazil BenefitFromForeignTaxMatterBrazil	30000000	USD
CY2021	cl	Write Off Of Certain Investments And Fixedassets WriteOffOfCertainInvestmentsAndFixedassets	10000000	USD
CY2020	cl	Write Off Of Certain Investments And Fixedassets WriteOffOfCertainInvestmentsAndFixedassets	0	USD
CY2019	cl	Write Off Of Certain Investments And Fixedassets WriteOffOfCertainInvestmentsAndFixedassets	51000000	USD
CY2021	cl	Business Combination Acquisition Related Costs Net BusinessCombinationAcquisitionRelatedCostsNet	0	USD
CY2020	cl	Business Combination Acquisition Related Costs Net BusinessCombinationAcquisitionRelatedCostsNet	2000000	USD
CY2019	cl	Business Combination Acquisition Related Costs Net BusinessCombinationAcquisitionRelatedCostsNet	21000000	USD
CY2021	cl	Restructuring And Related Cost Incurred Cost Related To Changes In Market Strategy RestructuringAndRelatedCostIncurredCostRelatedToChangesInMarketStrategy	0	USD
CY2020	cl	Restructuring And Related Cost Incurred Cost Related To Changes In Market Strategy RestructuringAndRelatedCostIncurredCostRelatedToChangesInMarketStrategy	0	USD
CY2019	cl	Restructuring And Related Cost Incurred Cost Related To Changes In Market Strategy RestructuringAndRelatedCostIncurredCostRelatedToChangesInMarketStrategy	15000000	USD
CY2021	cl	Other Income Expense Net OtherIncomeExpenseNet	4000000	USD
CY2020	cl	Other Income Expense Net OtherIncomeExpenseNet	48000000	USD
CY2019	cl	Other Income Expense Net OtherIncomeExpenseNet	29000000	USD
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-65000000	USD
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-113000000	USD
CY2019	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-196000000	USD
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	195000000	USD
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	184000000	USD
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	193000000	USD
CY2021	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	3000000	USD
CY2020	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	1000000	USD
CY2019	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	1000000	USD
CY2021	us-gaap	Interest Income Other InterestIncomeOther	17000000	USD
CY2020	us-gaap	Interest Income Other InterestIncomeOther	19000000	USD
CY2019	us-gaap	Interest Income Other InterestIncomeOther	47000000	USD
CY2021	cl	Interest Expense Net InterestExpenseNet	175000000	USD
CY2020	cl	Interest Expense Net InterestExpenseNet	164000000	USD
CY2019	cl	Interest Expense Net InterestExpenseNet	145000000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	307000000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	290000000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	281000000	USD
CY2021	us-gaap	Advertising Expense AdvertisingExpense	2021000000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	1948000000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	1694000000	USD
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	505000000	USD
CY2020Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	454000000	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	39000000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	45000000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1248000000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1256000000	USD
CY2021Q4	cl	Inventory Net Including Noncurrent InventoryNetIncludingNoncurrent	1792000000	USD
CY2020Q4	cl	Inventory Net Including Noncurrent InventoryNetIncludingNoncurrent	1755000000	USD
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	100000000	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	82000000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	1692000000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1673000000	USD
CY2021Q4	us-gaap	Lifo Inventory Amount LIFOInventoryAmount	410000000	USD
CY2020Q4	us-gaap	Lifo Inventory Amount LIFOInventoryAmount	439000000	USD
CY2021Q4	us-gaap	Excess Of Replacement Or Current Costs Over Stated Lifo Value ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue	60000000	USD
CY2020Q4	us-gaap	Excess Of Replacement Or Current Costs Over Stated Lifo Value ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue	65000000	USD
CY2021Q4	us-gaap	Land Land	163000000	USD
CY2020Q4	us-gaap	Land Land	166000000	USD
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1603000000	USD
CY2020Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1623000000	USD
CY2021Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	5527000000	USD
CY2020Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	5409000000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	1606000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	1553000000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8899000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8751000000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5169000000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5035000000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3730000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3716000000	USD
CY2021Q4	cl	Accrued Advertising And Coupon Redemption Current AccruedAdvertisingAndCouponRedemptionCurrent	709000000	USD
CY2020Q4	cl	Accrued Advertising And Coupon Redemption Current AccruedAdvertisingAndCouponRedemptionCurrent	728000000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	353000000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	401000000	USD
CY2021Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	118000000	USD
CY2020Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	116000000	USD
CY2021Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	7000000	USD
CY2020Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	21000000	USD
CY2021Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	87000000	USD
CY2020Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	89000000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	137000000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	137000000	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	38000000	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	39000000	USD
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	6000000	USD
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	93000000	USD
CY2021Q4	cl	Other Accrued Liabilities Current Other OtherAccruedLiabilitiesCurrentOther	630000000	USD
CY2020Q4	cl	Other Accrued Liabilities Current Other OtherAccruedLiabilitiesCurrentOther	717000000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2085000000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2341000000	USD
CY2021Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	1722000000	USD
CY2020Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	1815000000	USD
CY2021Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	2000000	USD
CY2020Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	10000000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	451000000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	476000000	USD
CY2021Q4	cl	Other Noncurrent Liability OtherNoncurrentLiability	254000000	USD
CY2020Q4	cl	Other Noncurrent Liability OtherNoncurrentLiability	354000000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2429000000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2655000000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	1044000000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	1178000000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-3349000000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-3158000000	USD

Files In Submission

Name	View Source	Status
0000021665-22-000003-index-headers.html	Edgar Link	pending
0000021665-22-000003-index.html	Edgar Link	pending
0000021665-22-000003.txt	Edgar Link	pending
0000021665-22-000003-xbrl.zip	Edgar Link	pending
cl-20211231.htm	Edgar Link	pending
cl-20211231.xsd	Edgar Link	pending
cl-20211231_cal.xml	Edgar Link	unprocessable
cl-20211231_def.xml	Edgar Link	unprocessable
cl-20211231_g1.jpg	Edgar Link	pending
cl-20211231_g2.jpg	Edgar Link	pending
cl-20211231_g3.jpg	Edgar Link	pending
cl-20211231_g4.jpg	Edgar Link	pending
cl-20211231_htm.xml	Edgar Link	completed
cl-20211231_lab.xml	Edgar Link	unprocessable
cl-20211231_pre.xml	Edgar Link	unprocessable
exhibit10-d12312021.htm	Edgar Link	pending
exhibit10-k12312021.htm	Edgar Link	pending
exhibit2112312021.htm	Edgar Link	pending
exhibit2312312021.htm	Edgar Link	pending
exhibit2412312021.htm	Edgar Link	pending
exhibit31a12312021.htm	Edgar Link	pending
exhibit31b12312021.htm	Edgar Link	pending
exhibit3212312021.htm	Edgar Link	pending
exhibit4a12312021.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CL
COLGATE PALMOLIVE CO Stock $cl

2021 Q4 Form 10-K Financial Statement

#000002166522000003 Filed on February 17, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CL COLGATE PALMOLIVE CO Stock $cl

2021 Q4 Form 10-K Financial Statement

#000002166522000003 Filed on February 17, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CL
COLGATE PALMOLIVE CO Stock $cl